- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02500771
Feasibility Testing and Pilot Study of V-MOTIVE Protocol Software Version 1
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rex Jakobovits, PhD
- Phone Number: 2065885811
- Email: rex@rexj.com
Study Locations
-
-
Washington
-
Bellevue, Washington, United States, 98004
- Northwest Behavioral Associates
-
Contact:
- Stacey Shook, PhD, BCBA-D
- Phone Number: 425-822-6442
- Email: sshook@nba-autism.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children between 4 and 10 years old
- Clinical diagnosis of Autism Spectrum Disorder
- Currently receiving Applied Behavioral Analysis therapy
- Must be developmentally capable of basic imitation behavior
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: children and tutors using V-Motive
The following intervention will be administered: ABA therapy enhanced with V-Motive software Tutors treating children with Applied Behavioral Analysis therapy will use the V-Motive software to enhance therapy sessions. Children will receive therapy as usual, but half of their current behavioral programs (skills/goals) will have been selected for enhanced prompting through video modeling. |
Tutors will use the V-Motive software to enhance their delivery of Applied Behavioral Analysis therapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of V-Motive software's ability to positively impact a child's performance within 4 weeks
Time Frame: 4-week trial starting in 2020
|
The following pilot feasibility measures will be captured for each tutor/child pair: 1) Usage: the total number of times the tutor chooses to use VM (an indicator that the tutor found it useful); 2) Overall Trial Success Rate: the percent of trials that were successful (e.g.
recorded as a "pass") in programs with and without VM; 3) Mastery: the trials to criteria and the total number of targets mastered with and without VM; 4) Behavior Impact: the number of tantrums and other tracked behaviors occurring with and without VM (tracked by tutor using Abacus behavior tracker).
|
4-week trial starting in 2020
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Amount of time required to construct a fully-indexed video repository from therapy footage using V-Motive
Time Frame: 4-week trial starting in 2020
|
Researchers will measure the time it takes to construct the video repository for each tutor (time spent setting up camera, initializing the upload process, etc).
|
4-week trial starting in 2020
|
Accuracy of V-Motive software in suggesting and cueing up appropriate video for playback on demand
Time Frame: 4-week trial starting in 2020
|
The system will automatically capture the number of times a tutor adjusts the video for playback, number of times a video is rewound or fast-forwarded to obtain the appropriate start time, and the amount of time spent seeking before the video is cued up for playback to the child.
For precision determination, actual start times will be obtained by manually reviewing the video of selected trials, and user seek times will be automatically tracked by the system.
|
4-week trial starting in 2020
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rex Jakobovits, Experiad LLC
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VMOTIVE-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on ABA therapy enhanced with V-Motive software
-
Babes-Bolyai UniversityUniversity of Plymouth; Vrije Universiteit Brussel; University of Portsmouth; University... and other collaboratorsCompletedAutistic Disorders SpectrumRomania
-
Chalmers University of TechnologySahlgrenska University Hospital, SwedenNot yet recruitingNeuropathic Pain | Phantom Limb PainSweden
-
Oslo University HospitalUniversity of Oslo; University Hospital of North Norway; University of California... and other collaboratorsRecruitingFeeding and Eating DisordersNorway
-
Penn State UniversityUniversity of Arizona; Proactive Life IncCompletedInsomnia | Alzheimers Disease Related DementiasUnited States
-
University of Missouri, Kansas CityNational Institute of Mental Health (NIMH)CompletedHIV Infections | Acquired Immunodeficiency SyndromeUnited States
-
Umm Al-Qura UniversityRecruitingPHYSICAL THERAPY TECHNIQUESSaudi Arabia
-
Charles University, Czech RepublicCompletedHyperglycemia | Cardiac SurgeryCzech Republic
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingGliosarcoma | MGMT-Unmethylated GlioblastomaUnited States
-
M.D. Anderson Cancer CenterRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Clinical Stage III Cutaneous Melanoma AJCC v8 and other conditionsUnited States
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV InfectionsUnited States, Puerto Rico, Thailand, Botswana, Argentina, Brazil, Tanzania, South Africa